Repotrectinib Alone and in Combination with Immunomodulatory Drugs Exhibits Potent Anti-Multiple Myeloma Activity

MLA

Haiming Chen, et al. “Repotrectinib Alone and in Combination with Immunomodulatory Drugs Exhibits Potent Anti-Multiple Myeloma Activity.” Blood, vol. 140, Nov. 2022, pp. 12460–61. EBSCOhost, https://doi.org/10.1182/blood-2022-167862.

APA

Haiming Chen, Eric Souther, Mingjie Li, Marissa-Skye Goldwater, Stacy Behare, Ava Hekmati, Huixin Yu, Isabella Nassir, Ariella Nassir, Ning Xu, & James R. Berenson. (2022). Repotrectinib Alone and in Combination with Immunomodulatory Drugs Exhibits Potent Anti-Multiple Myeloma Activity. Blood, 140, 12460–12461. https://doi.org/10.1182/blood-2022-167862

Chicago

Haiming Chen, Eric Souther, Mingjie Li, Marissa-Skye Goldwater, Stacy Behare, Ava Hekmati, Huixin Yu, et al. 2022. “Repotrectinib Alone and in Combination with Immunomodulatory Drugs Exhibits Potent Anti-Multiple Myeloma Activity.” Blood 140 (November): 12460–61. doi:10.1182/blood-2022-167862.